Ocular Therapeutix (OCUL) Appoints Donald Notman as COO
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Join SI Premium – FREE
On August 29, 2024, the board of directors of Ocular Therapeutix (NASDAQ: OCUL) appointed Donald Notman to serve as Chief Operating Officer of the Company. In addition to his new role, Mr. Notman will continue to serve as Chief Financial Officer of the Company as well as its principal financial and accounting officer.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cadrenal Therapeutics CMO resigns, separation terms disclosed
- ACI Worldwide exploring sale of billing division - Reuters
- DBV Technologies refreshes ATM program with $150M ADS offering
Create E-mail Alert Related Categories
8K, Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
